Bessler Robert 4

What happened

• Robert Bessler, a director of LifeStance Health Group, sold a total of 69,899 shares in open‑market/private sale transactions on April 23–24, 2026, generating aggregate proceeds of approximately $492,401. The trades were reported on a Form 4 filed April 27, 2026.
• Transactions listed: 3,876 shares at $7.00 (x2) and 31,073 and 31,074 shares at $7.05; reported proceeds per line: $27,132, $27,132, $219,065, and $219,072.

Key details

• Transaction dates and prices:
  • Apr 23, 2026: two disposals of 3,876 shares each at a reported $7.00 (weighted average; actual prices ranged $7.00–$7.005).
  • Apr 24, 2026: disposals of 31,073 and 31,074 shares at a reported $7.05 (weighted average; actual prices ranged $7.00–$7.095).
• Total shares sold: 69,899; total proceeds: ≈ $492,401.
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Notable footnotes from the filing:
  • Weighted‑average prices reported; seller will provide details of number of shares sold at each separate price on request (F1, F4).
  • Reporting person disclaims beneficial ownership except for pecuniary interest (F2, F3).
  • Some shares were held of record by Alpine Glow Capital; Bessler is manager and sole member of that entity (F5).
• Filing timeliness: Form 4 was filed Apr 27, 2026; based on trade dates (Apr 23–24) the filing appears timely under Section 16 reporting deadlines.

Context

• These were sales (S), which are common for insiders for liquidity or portfolio reasons; sales generally convey less clear sentiment than purchases. No indication in the filing that these were option exercises, awards, or gifts.
• The weighted‑average and price‑range footnotes mean the shares were sold across multiple executions at slightly varying prices within the ranges noted.